Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2014 1
2018 1
2019 1
2020 4
2021 2
2022 1
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
Horn L, Mansfield AS, Szczęsna A, Havel L, Krzakowski M, Hochmair MJ, Huemer F, Losonczy G, Johnson ML, Nishio M, Reck M, Mok T, Lam S, Shames DS, Liu J, Ding B, Lopez-Chavez A, Kabbinavar F, Lin W, Sandler A, Liu SV; IMpower133 Study Group. Horn L, et al. N Engl J Med. 2018 Dec 6;379(23):2220-2229. doi: 10.1056/NEJMoa1809064. Epub 2018 Sep 25. N Engl J Med. 2018. PMID: 30280641 Clinical Trial.
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions.
Zhou C, Tang KJ, Cho BC, Liu B, Paz-Ares L, Cheng S, Kitazono S, Thiagarajan M, Goldman JW, Sabari JK, Sanborn RE, Mansfield AS, Hung JY, Boyer M, Popat S, Mourão Dias J, Felip E, Majem M, Gumus M, Kim SW, Ono A, Xie J, Bhattacharya A, Agrawal T, Shreeve SM, Knoblauch RE, Park K, Girard N; PAPILLON Investigators. Zhou C, et al. N Engl J Med. 2023 Nov 30;389(22):2039-2051. doi: 10.1056/NEJMoa2306441. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870976 Clinical Trial.
Unbalanced T-cell subsets in pediatric patients with beta-thalassemia.
Namazi Bayegi S, Ali Hamidieh A, Behfar M, Saghazadeh A, Bozorgmehr M, Tajik N, Delbandi AA, Delavari S, Shekarabi M, Rezaei N. Namazi Bayegi S, et al. Hum Immunol. 2023 Mar;84(3):224-234. doi: 10.1016/j.humimm.2022.12.003. Epub 2023 Jan 4. Hum Immunol. 2023. PMID: 36604193
A Novel Link between the Oxytocin Receptor Gene and Impulsivity.
Bozorgmehr A, Moayedi R, Sadeghi B, Ghadirivasfi M, Joghataei MT, Shahbazi A. Bozorgmehr A, et al. Neuroscience. 2020 Sep 15;444:196-208. doi: 10.1016/j.neuroscience.2020.07.033. Epub 2020 Jul 25. Neuroscience. 2020. PMID: 32717294
Human menstrual blood-derived stromal/stem cells modulate functional features of natural killer cells.
Shokri MR, Bozorgmehr M, Ghanavatinejad A, Falak R, Aleahmad M, Kazemnejad S, Shokri F, Zarnani AH. Shokri MR, et al. Sci Rep. 2019 Jul 10;9(1):10007. doi: 10.1038/s41598-019-46316-3. Sci Rep. 2019. PMID: 31292483 Free PMC article.
Of 41 growth factors tested, MenSCs produced lower levels of insulin-like growth factor binding proteins (IGFBPs) 1-4, VEGF-A, beta-NGF, and M-CSF compared to bone marrow-derived mesenchymal stem cells (BMSCs). ...
Of 41 growth factors tested, MenSCs produced lower levels of insulin-like growth factor binding proteins (IGFBPs) 1-4, VEGF-A, beta-NGF, and …
Acrocyanosis and Progressive Skin Necrosis as Manifestation of Waldenstrom Macroglobulinemia Associated With Type I Cryoglobulinemia: A Case Report.
Nekooghadam SM, Bozorgmehr R, Safavi-Naini SAA. Nekooghadam SM, et al. Int J Low Extrem Wounds. 2023 Sep;22(3):605-609. doi: 10.1177/15347346211026994. Epub 2021 Jun 24. Int J Low Extrem Wounds. 2023. PMID: 34166124
Waldenstrom macroglobulinemia (WM), a rare malignant disorder, occurs as a result of abnormal proliferation of lymphocytes that produce immunoglobulin M. In rare cases, WM complicates by type I cryoglobulinemia. Type I cryoglobulinemia usually presents with cutaneous manif …
Waldenstrom macroglobulinemia (WM), a rare malignant disorder, occurs as a result of abnormal proliferation of lymphocytes that produce immu …
The Quality of SARS-CoV-2-Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated.
Shahbaz S, Xu L, Sligl W, Osman M, Bozorgmehr N, Mashhouri S, Redmond D, Perez Rosero E, Walker J, Elahi S. Shahbaz S, et al. J Immunol. 2021 Aug 15;207(4):1099-1111. doi: 10.4049/jimmunol.2100446. Epub 2021 Jul 26. J Immunol. 2021. PMID: 34312258
In this study, we explored and compared the effector functions of SARS-CoV-2-reactive T cells expressing coinhibitory receptors and examine the immunogenicity of SARS-CoV-2 S, M, and N peptide pools in regard to specific effector T cell responses, Th1/Th2/Th17, in COVID-19 …
In this study, we explored and compared the effector functions of SARS-CoV-2-reactive T cells expressing coinhibitory receptors and examine …
16 results